We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| DuPont de Nemours Inc | NYSE:DD | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.11 | -0.15% | 73.80 | 73.90 | 73.32 | 73.41 | 1,539,380 | 01:00:00 |
From Apr 2019 to Apr 2024
By Chris Wack
DuPont said Friday that its board of directors has approved the separation of its Nutrition & Biosciences business through an exchange offer.
The company said DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences Inc. common stock. The separation will be followed by the simultaneous combination of Nutrition & Biosciences with International Flavors & Fragrances in a Reverse Morris Trust transaction in which shares of Nutrition & Biosciences common stock will be converted into shares of IFF common stock.
DuPont will announce the offer terms at launch of the exchange offer. If the split-off isn't fully subscribed, the remaining shares of Nutrition & Biosciences will be distributed through a pro rata spin-off to DuPont stockholders.
DuPont said it sees the closing of the IFF and Nutrition & Biosciences on Feb. 1, 2021.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
December 18, 2020 06:36 ET (11:36 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year DuPont de Nemours Chart |
1 Month DuPont de Nemours Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
